English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jan 30, 2026

FDA recommends using minimal residual disease as key endpoint for multiple myeloma drug approvals
+ Pharmaceuticals
Patient Daily | Jan 30, 2026

Senate gridlock delays decision on rare disease priority review voucher program
+ Pharmaceuticals
Patient Daily | Jan 30, 2026

Ohio State experts warn against routine use of biotin supplements after cancer
+ Pharmaceuticals
Patient Daily | Jan 29, 2026

Biopharma sector sees increased hiring plans despite recent layoffs
+ Pharmaceuticals
Patient Daily | Jan 29, 2026

Baylor College of Medicine appoints Fred Seigel and Gina Luna to board
+ Pharmaceuticals
Patient Daily | Jan 29, 2026

Biotech investors discuss deal trends and strategy shifts on Denatured podcast
+ Pharmaceuticals
Patient Daily | Jan 29, 2026

Northwestern Medicine team develops artificial lung system enabling double-lung transplant after total pneumonectomy
+ Pharmaceuticals
Patient Daily | Jan 29, 2026

Ten companies seek IT professionals amid rising biotech job postings

Trending
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns